Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Forte Biosciences, Inc. (FBRX) had Weighted-Average Shares Outstanding (Basic) of 11.40M for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
-- |
|
$-15.66M |
|
-- |
|
-- |
|
$16.12M |
|
$-16.12M |
|
$0.47M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-16.12M |
|
$-16.11M |
|
Weighted-Average Shares Outstanding (Basic) |
11.40M |
11.40M |
|
$-1.37 |
|
$-1.37 |
|
Balance Sheet Financials | |
$47.16M |
|
$0.12M |
|
$0.30M |
|
$47.46M |
|
$9.03M |
|
-- |
|
-- |
|
$9.03M |
|
$38.43M |
|
$38.43M |
|
$38.43M |
|
6.58M |
|
Cash Flow Statement Financials | |
$-10.36M |
|
$36.29M |
|
$-2.32M |
|
$22.24M |
|
$45.86M |
|
$23.61M |
|
$1.62M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
5.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-40.74% |
|
-40.74% |
|
-32.99% |
|
-40.74% |
|
$5.84 |
|
$-0.91 |
|
$-0.91 |